Miranda So, McGill University

Research

Immunomodulation Platform Trial Pneumocystis Pneumonia Randomized Controlled Trial Secondary Prophylaxis Treatment

Latest funding

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
CIHR · 2024 · Principal investigator
$1,683,000

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

Principal investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Benedetti, Andrea; Bhagani, Sanjay; Boyles, Tom; Butler-Laporte, Guillaume; Cheng, Matthew P; McDonald, Emily G; McGuinty, Michaeline; Nakashima, Kei; Schwartz, Ilan S; Slavin, Monica; So, Miranda; Tan, Darrell H; Yong, Michelle

Keywords: Immunomodulation; Platform Trial; Pneumocystis; Pneumonia; Randomized Controlled Trial; Secondary Prophylaxis; Treatment

$1,683,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2024

Subject: Prospective PhD student: Immunomodulation Dear Professor So, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on immunomodulation connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]